Stock SGTX SIGILON THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders Sigilon Therapeutics, Inc.

Equities

SGTX

US82657L2060

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sigilon Therapeutics, Inc. Announces Board Changes
CI
Sigilon Therapeutics, Inc. Terminates the Employment of May Orfali as Chief Medical Officer
CI
Sigilon Therapeutics, Inc. Announces Resignation of Brooke Story from Her Position as Member of the Board of Directors and Any Committees Thereof
CI
Sigilon Therapeutics, Inc. Appoints Josias Fantato De Pontes as Treasurer
CI
Sigilon Therapeutics, Inc. Appoints Josias Fantato De Pontes as Acting Chief Financial Officer Replacing Rogerio Vivaldi
CI
Sigilon Therapeutics, Inc. Appoints Sarah Yuan as Chief Technical Operations Officer
CI
Sigilon Therapeutics, Inc. Announces Management Appointments
CI
Sigilon Therapeutics, Inc. Announces Resignation of Deya Corzo as Chief Medical Officer
CI
Sigilon Therapeutics Appoints Ajay Rai as Senior Vice President, Head of Business Development
CI
Sigilon Therapeutics, Inc. Announces Management Changes
CI
Sigilon Therapeutics, Inc. Announces Resignation of Glenn Reicin as the Chief Financial Officer, Effective June 14, 2021
CI
Sigilon Therapeutics, Inc. Appoints Philip Ashton-Rickardt as Chief Scientific Officer
CI
Sigilon Therapeutics Appoints Kavita Patel, M.D., to Its Board of Directors
CI
Sigilon Therapeutics Appoints John Cox to its Board of Directors
CI
Sigilon Therapeutics Announces Executive Appointments
CI
Sigilon Therapeutics Announces Executive Changes
CI
Sigilon Therapeutics, Inc. Appoints Eric Shaff to its Board of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SGTX Stock
  4. News Sigilon Therapeutics, Inc.
  5. Insiders